Open main menu
Search Ctrl + K
Free Trial
Loading...
Halozyme Therapeutics, Inc.
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.HALO
12390 El Camino Real, San Diego, CA, 92130
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Latest Filings – Ownership
SC 13G/A
12 Nov 24
SC 13G
17 Oct 24
144
Michael Labarre
16 Oct 24
4
Labarre Michael J.
16 Oct 24
144
Michael Labarre
15 Oct 24
144
Helen Torley
09 Oct 24
4
Torley Helen
09 Oct 24
144
Helen Torley
08 Oct 24
144
Helen Torley
26 Sep 24
4
Torley Helen
26 Sep 24
144
Helen Torley
25 Sep 24
144
Helen Torley
24 Sep 24
144
Michael Labarre
18 Sep 24
4
Labarre Michael J.
18 Sep 24
144
Michael Labarre
17 Sep 24
4
Torley Helen
12 Sep 24
144
Helen Torley
12 Sep 24
144
Helen Torley
11 Sep 24
144
Helen Torley
10 Sep 24
4
Labarre Michael J.
27 Aug 24
Latest Filings – Non-Ownership
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
31 Oct 24
10-Q
Quarterly Filing
31 Oct 24
10-Q
Quarterly Filing
06 Aug 24
10-Q
Quarterly Filing
07 May 24
8-K
Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
26 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
15 Mar 24
ARS
Scanned Paper Annual Report Submission.
15 Mar 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
15 Mar 24
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
04 Mar 24
10-K
Fiscal Year 2024
20 Feb 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
20 Feb 24
8-K
Results Of Operations And Financial Condition
17 Jan 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
06 Nov 23
10-Q
Quarterly Filing
06 Nov 23
8-K
Other Events
07 Sep 23
10-Q
Quarterly Filing
08 Aug 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 23
UPLOAD
Letter From The Sec.
21 Jul 23
CORRESP
Correspondence With The Sec.
28 Jun 23
10-Q
Quarterly Filing
09 May 23